Personalized Nutraceutical Delivery System with AI, IoT, and Blockchain Integration

Publication ID: 24-11857593_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Personalized Nutraceutical Delivery System with AI, IoT, and Blockchain Integration,” Published Technical Disclosure No. 24-11857593_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857593_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,593.

Summary of the Inventive Concept

A novel system integrating AI, IoT, and blockchain technologies to provide personalized nutraceutical gel compositions tailored to individual users' health needs and preferences.

Background and Problem Solved

The original patent for nutraceutical gels addressed the need for effective immune modulators in gel-based matrix. However, the patented invention had limitations in terms of personalization and customization. The new inventive concept solves this problem by leveraging AI, IoT, and blockchain technologies to create a system that can monitor user health data, analyze nutritional requirements, and provide customized nutraceutical gel composition recommendations.

Detailed Description of the Inventive Concept

The system comprises a wearable IoT device that monitors user health data, a blockchain-based data storage that securely stores user data and composition formulations, and an AI-powered optimization algorithm that integrates user health data, environmental factors, and nutritional requirements to formulate customized nutraceutical gel compositions. The system generates unique QR codes for each composition, linking to the blockchain-based data storage and providing access to the composition's formulation and manufacturing history. The nutraceutical gel composition itself can be formulated using a galactomannan-based matrix infused with nanoparticles containing an immune modulator, designed to release the immune modulator in response to specific physiological conditions detected by the wearable IoT device.

Novelty and Inventive Step

The new claims introduce the innovative integration of AI, IoT, and blockchain technologies to provide personalized nutraceutical delivery, which is not anticipated by the original patent. The use of AI-powered optimization algorithms, wearable IoT devices, and blockchain-based data storage creates a novel system that is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the system could include the use of different types of wearable devices, such as smartwatches or fitness trackers, or the integration of additional data sources, such as environmental sensors or genetic data. Variations of the nutraceutical gel composition could include different matrix materials or immune modulators, or the use of different types of nanoparticles or release mechanisms.

Potential Commercial Applications and Market

The personalized nutraceutical delivery system has significant commercial potential in the health and wellness industry, particularly in the areas of preventative medicine and personalized nutrition. The system's ability to provide customized compositions and track user health data could appeal to consumers seeking tailored health solutions, and the use of blockchain technology could provide a secure and transparent platform for data storage and sharing.

CPC Classifications

SectionClassGroup
A A61 A61K36/889
A A23 A23G4/12
A A23 A23L29/231
A A23 A23L29/238
A A23 A23L29/27
A A23 A23L29/271
A A23 A23L29/284
A A23 A23L33/10
A A23 A23L33/105
A A61 A61K36/185
A A61 A61K36/35
A A61 A61K36/87
A A61 A61K47/36
A A23 A23V2002/00
A A23 A23V2200/324
A A23 A23V2250/21
A A23 A23V2250/21166
A A23 A23V2250/506
A A23 A23V2250/5086
A A23 A23V2250/708
A A61 A61K2300/00

Original Patent Information

Patent NumberUS 11,857,593
TitleNutraceutical gels
Assignee(s)4Life Patents, LLC